-
Par Pharmaceutical, Inc. et al v. Amneal Pharmaceuticals of New York, LLC, et al., DC
- 1:18-cv-02032
- D. Del.
- Filed: 12/20/2018
- Closed: 02/09/2022
- Latest Docket Entry: 03/02/2022
- Judge: Colm F. Connolly
+1
- PACER
3
Plaintiffs
8
Defendants
1
Accused
Product
6
Patents-in-Suit
1,148
Days in
Litigation
-
Par Pharmaceutical, Inc. et al v. Amneal Pharmaceuticals of New York, LLC, et al., DC
- 1:18-cv-02032
- D. Del.
- Filed: 12/20/2018
- Closed: 02/09/2022
- Latest Docket Entry: 03/02/2022
- Judge: Colm F. Connolly
+1
- PACER
Cause of Action
Infringement
Assigned Judge
Outcome Summary
Patent Information
-
Infringement
American Regent, Inc.
- 4 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| VASOSTRICT® Vasopressin Injection USP 20 units/1 mL vials | US 9,375,478 B1 | All Asserted Claims |
Infringement
Entry 108
|
| VASOSTRICT® Vasopressin Injection USP 20 units/1 mL vials | US 9,687,526 B2 | All Asserted Claims |
Infringement
Entry 108
|
| VASOSTRICT® Vasopressin Injection USP 20 units/1 mL vials | US 9,744,209 B2 | All Asserted Claims |
Infringement
Entry 108
|
| VASOSTRICT® Vasopressin Injection USP 20 units/1 mL vials | US 9,750,785 B2 | All Asserted Claims |
Infringement
Entry 108
|